Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma

NCT06616688 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06616688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06616688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma (pdac)